4.6 Article

Redefining the hypotheses driving Parkinson's diseases research

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Letter Gastroenterology & Hepatology

Global prediction of primary liver cancer incidences and mortality in 2040

Chenxi Li et al.

JOURNAL OF HEPATOLOGY (2023)

Article Genetics & Heredity

Machine Learning Identifies Six Genetic Variants and Alterations in the Heart Atrial Appendage as Key Contributors to PD Risk Predictivity

Daniel Ho et al.

Summary: Parkinson's disease is a complex neurodegenerative disease with various genetic loci and variants associated. This study used a machine learning approach to analyze tissue-specific eQTL data and identified key genetic variants and transcriptional changes related to PD risk and disease development.

FRONTIERS IN GENETICS (2022)

Article Clinical Neurology

The Rostock International Parkinson's Disease (ROPAD) Study: Protocol and Initial Findings

Volha Skrahina et al.

Summary: The ROPAD study aims to genetically characterize around 10,000 Parkinson's disease patients, with initial data from 1360 participants indicating a genetic diagnostic yield of approximately 14%. This demonstrates the feasibility and effectiveness of the screening protocol for high-throughput genetic characterization and prioritization for research efforts and clinical trials.

MOVEMENT DISORDERS (2021)

Article Clinical Neurology

Heritability Enrichment Implicates Microglia in Parkinson's Disease Pathogenesis

Maren Stolp Andersen et al.

Summary: By studying immune and brain cell types, this research found a genetic enrichment of Parkinson's disease, particularly in microglia and monocytes. The results provide further support for the importance of immune mechanisms in Parkinson's disease pathogenesis and highlight microglial dysregulation as a contributing etiological factor. A targetable microglial gene has been nominated as a key player in the pathogenic process, with potential implications for future treatment in Parkinson's disease.

ANNALS OF NEUROLOGY (2021)

Article Multidisciplinary Sciences

Integration of Alzheimer's disease genetics and myeloid genomics identifies disease risk regulatory elements and genes

Gloriia Novikova et al.

Summary: This study integrates Alzheimer's disease (AD) GWAS data with myeloid cell genomics, and reports that myeloid active enhancers are most burdened by AD risk alleles. The authors also nominate candidate causal regulatory elements, variants and genes that likely modulate the risk for AD.

NATURE COMMUNICATIONS (2021)

Review Neurosciences

Parkinson's Disease Subtypes: Critical Appraisal and Recommendations

Tiago A. Mestre et al.

Summary: The studies on PD subtypes have methodological shortcomings and questionable clinical applicability. Most studies did not achieve the highest rating on methodological quality checklists. The clinical importance of differences between subtypes and their potential treatment implications were rated poorly, indicating a need for new approaches that acknowledge individual-level heterogeneity and personalized medicine.

JOURNAL OF PARKINSONS DISEASE (2021)

Article Genetics & Heredity

Validity and Prognostic Value of a Polygenic Risk Score for Parkinson's Disease

Sebastian Koch et al.

Summary: Idiopathic Parkinson's disease is a complex disorder influenced by both genetic and non-genetic factors. Polygenic risk scores can help predict disease risk, but the study found that the PD-PRS performs poorly in predicting the development of PD in healthy individuals.
Review Medicine, General & Internal

Parkinson's disease

Bastiaan R. Bloem et al.

Summary: Parkinson's disease is a neurodegenerative condition with diverse causes and clinical presentations. Diagnosis is clinically based, and treatment goals vary from person to person, emphasizing the need for personalized management. Currently, there is no therapy to slow down or arrest the progression of Parkinson's disease.

LANCET (2021)

Article Clinical Neurology

Intronic Haplotypes in the GBA Gene Do Not Predict Age at Diagnosis of Parkinson's Disease

Marco Toffoli et al.

Summary: Through studying a large cohort, we found that GBA haplotypes do not affect age at diagnosis of PD.

MOVEMENT DISORDERS (2021)

Letter Clinical Neurology

Intronic Haplotypes in GBA Modify Age at Diagnosis of Parkinson's: Replication in a Subgroup

Justin M. O'Sullivan et al.

MOVEMENT DISORDERS (2021)

Article Genetics & Heredity

Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease

Ganqiang Liu et al.

Summary: A genome-wide survival study identified variants at RIMS2 associated with progression of Parkinson's disease to dementia and highlights divergence in the genetic architecture of disease onset and progression.

NATURE GENETICS (2021)

Review Clinical Neurology

Prodromal Parkinson disease subtypes - key to understanding heterogeneity

Daniela Berg et al.

Summary: Parkinson's disease begins its pathological processes and neurodegeneration long before clinical diagnosis, allowing for identification of individuals likely to develop the disease through risk and prodromal markers. Heterogeneity in clinical and prodromal PD suggests that subtypes exist, differentiated by clinical manifestations, pathomechanisms, and progression patterns. Understanding this variability is crucial for early and accurate diagnosis, as well as for targeting neuroprotective interventions effectively.

NATURE REVIEWS NEUROLOGY (2021)

Article Medicine, General & Internal

Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial

Michael A. Schwarzschild et al.

Summary: In this randomized clinical trial, treatment with oral inosine for up to 2 years did not slow the progression of Parkinson disease in early stage patients. The study found that there was no significant difference in clinical disease progression between the inosine group and the placebo group.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Biochemistry & Molecular Biology

Wearable sensors enable personalized predictions of clinical laboratory measurements

Jessilyn Dunn et al.

Summary: Data collected from wearable devices can predict clinical laboratory measurements more accurately than clinically obtained vital sign measurements, demonstrating the potential value of commercial wearable devices in assessing physiological measurements and potentially replacing some laboratory tests.

NATURE MEDICINE (2021)

Article Clinical Neurology

The Role of Intermittent Fasting in Parkinson's Disease

Bryan J. Neth et al.

FRONTIERS IN NEUROLOGY (2021)

Review Cardiac & Cardiovascular Systems

Network medicine in Cardiovascular Research

Laurel Y. Lee et al.

Summary: Network medicine views diseases as the consequences of perturbed interactions between multiple interconnected biological components, facilitating a deeper understanding of complex disease mechanisms. The limitations associated with traditional reductionist analytical methods are apparent, whereas the concept of network medicine provides a new approach to advancing cardiovascular disease research.

CARDIOVASCULAR RESEARCH (2021)

Review Cardiac & Cardiovascular Systems

Network medicine in Cardiovascular Research

Laurel Y. Lee et al.

Summary: Network medicine views diseases as consequences of perturbed interactions between multiple interconnected biological components, and plays a crucial role in studying complex disease mechanisms. It has the potential to accelerate cardiovascular disease research and advance precision medicine.

CARDIOVASCULAR RESEARCH (2021)

Article Biotechnology & Applied Microbiology

CellWalker integrates single-cell and bulk data to resolve regulatory elements across cell types in complex tissues

Pawel F. Przytycki et al.

Summary: The CellWalker method integrates single-cell open chromatin data with gene expression and other data types to improve cell labeling in noisy data and annotate cell type-specific regulatory elements in bulk data. Applying CellWalker to the developing brain allows for identification of cells transitioning between transcriptional states, resolving regulatory elements to cell types, and mapping traits like autism to specific cell types through their regulatory elements.

GENOME BIOLOGY (2021)

Article Clinical Neurology

Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson's Disease

Manuela M. X. Tan et al.

Summary: The study found that genetic variants associated with Parkinson's disease risk are not linked to disease progression. The APOE epsilon 4 tagging variant was significantly associated with cognitive progression, while ATP8B2 gene showed a nominal association with motor progression. The new method shows promise in improving the measurement of symptom progression in PD.

MOVEMENT DISORDERS (2021)

Review Chemistry, Medicinal

Leucine-rich repeat kinase 2 inhibitors: a patent review (2014-present)

Xiao Ding et al.

EXPERT OPINION ON THERAPEUTIC PATENTS (2020)

Article Clinical Neurology

Precision medicine in Parkinson's disease: emerging treatments for genetic Parkinson's disease

Susanne A. Schneider et al.

JOURNAL OF NEUROLOGY (2020)

Review Neurosciences

The Association Between Type 2 Diabetes Mellitus and Parkinson's Disease

Julia L. Y. Cheong et al.

JOURNAL OF PARKINSONS DISEASE (2020)

Article Clinical Neurology

Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson's Disease Onset

William Schierding et al.

MOVEMENT DISORDERS (2020)

Review Geriatrics & Gerontology

Chasing Protection in Parkinson's Disease: Does Exercise Reduce Risk and Progression?

Grace F. Crotty et al.

FRONTIERS IN AGING NEUROSCIENCE (2020)

Editorial Material Multidisciplinary Sciences

Single cell transcriptomics comes of age

Sarah Aldridge et al.

NATURE COMMUNICATIONS (2020)

Article Geriatrics & Gerontology

Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: The Cincinnati Cohort Biomarker Program (CCBP)

Andrea Sturchio et al.

FRONTIERS IN AGING NEUROSCIENCE (2020)

Article Clinical Neurology

PR001 gene therapy improved phenotypes in models of Parkinson’s disease with GBA1 mutation

Patty Sheehan et al.

Alzheimers & Dementia (2020)

Review Genetics & Heredity

Integrative single-cell analysis

Tim Stuart et al.

NATURE REVIEWS GENETICS (2019)

Review Immunology

Exploring the Multiple-Hit Hypothesis of Neurodegenerative Disease: Bacterial Infection Comes Up to Bat

Kristin L. Patrick et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)

Editorial Material Oncology

Levodopa treatment in Parkinson's disease: earlier or later?

Federico Paolini Paoletti et al.

ANNALS OF TRANSLATIONAL MEDICINE (2019)

Article Clinical Neurology

Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics

Konstantin Senkevich et al.

PARKINSONISM & RELATED DISORDERS (2019)

Article Biochemistry & Molecular Biology

A Genome-wide Framework for Mapping Gene Regulation via Cellular Genetic Screens

Molly Gasperini et al.

Article Clinical Neurology

The association between lifestyle factors and Parkinson's disease progression and mortality

Kimberly C. Paul et al.

MOVEMENT DISORDERS (2019)

Review Neurosciences

Triggers, Facilitators, and Aggravators: Redefining Parkinson's Disease Pathogenesis

Michaela E. Johnson et al.

TRENDS IN NEUROSCIENCES (2019)

Article Multidisciplinary Sciences

Double-slit photoelectron interference in strong-field ionization of the neon dimer

Maksim Kunitski et al.

NATURE COMMUNICATIONS (2019)

Review Clinical Neurology

Making the switch: From case studies to N-of-1 trials

Amanda Margolis et al.

EPILEPSY & BEHAVIOR REPORTS (2019)

Review Biotechnology & Applied Microbiology

Drug repurposing: progress, challenges and recommendations

Sudeep Pushpakom et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Review Biochemistry & Molecular Biology

The Emerging Potential for Network Analysis to Inform Precision Cancer Medicine

Kivilcim Ozturk et al.

JOURNAL OF MOLECULAR BIOLOGY (2018)

Article Clinical Neurology

Features of GBA-associated Parkinson's disease at presentation in the UK Tracking Parkinson's study

Naveed Malek et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)

Article Neurosciences

Precision Medicine in Parkinson's Disease - Exploring Patient-Initiated Self-Tracking

Sara Riggare et al.

JOURNAL OF PARKINSONS DISEASE (2018)

Article Clinical Neurology

Precision medicine for disease modification in Parkinson disease

Alberto J. Espay et al.

NATURE REVIEWS NEUROLOGY (2017)

Article Ecology

The infinitesimal model: Definition, derivation, and implications

N. H. Barton et al.

THEORETICAL POPULATION BIOLOGY (2017)

Review Neurosciences

The Threshold Theory for Parkinson's Disease

Simone Engelender et al.

TRENDS IN NEUROSCIENCES (2017)

Review Biochemistry & Molecular Biology

An Expanded View of Complex Traits: From Polygenic to Omnigenic

Evan A. Boyle et al.

Article Multidisciplinary Sciences

Enrichment of risk SNPs in regulatory regions implicate diverse tissues in Parkinson's disease etiology

Simon G. Coetzee et al.

SCIENTIFIC REPORTS (2016)

Review Clinical Neurology

Gastrointestinal dysfunction in Parkinson's disease

Alfonso Fasano et al.

LANCET NEUROLOGY (2015)

Editorial Material Multidisciplinary Sciences

Time for one-person trials

Nicholas J. Schork

NATURE (2015)

Article Genetics & Heredity

LD Score regression distinguishes confounding from polygenicity in genome-wide association studies

Brendan K. Bulik-Sullivan et al.

NATURE GENETICS (2015)

Article Clinical Neurology

PREDICT-PD: Identifying risk of Parkinson's disease in the community: methods and baseline results

Alastair J. Noyce et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)

Article Clinical Neurology

Exposure to pesticides or solvents and risk of Parkinson disease

Gianni Pezzoli et al.

NEUROLOGY (2013)

Editorial Material Multidisciplinary Sciences

Paths from Pesticides to Parkinson's

Freya Kamel

SCIENCE (2013)

Review Genetics & Heredity

Network medicine: a network-based approach to human disease

Albert-Laszlo Barabasi et al.

NATURE REVIEWS GENETICS (2011)

Review Pharmacology & Pharmacy

The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?

Elizabeth O. Lillie et al.

PERSONALIZED MEDICINE (2011)

Review Clinical Neurology

There is no Parkinson disease

William J. Weiner

ARCHIVES OF NEUROLOGY (2008)

Article Clinical Neurology

The Parkinson's complex: Parkinsonism is just the tip of the iceberg

JW Langston

ANNALS OF NEUROLOGY (2006)